Diagnostics and treatment of Miller-Fisher syndrome
- Authors: Ponomarev V.V.1
-
Affiliations:
- Clinical Hospital № 5
- Issue: Vol XXVII, No 1-2 (1995)
- Pages: 40-41
- Section: Articles
- URL: https://ogarev-online.ru/1027-4898/article/view/78641
- DOI: https://doi.org/10.17816/nb78641
- ID: 78641
Cite item
Full Text
Abstract
Miller-Fisher syndrome (SMF) is a rare disease in neurology and, according to most researchers, is a variant of Guillain-Barré polyradiculoneuritis. The SMF was first described in 1956. The clinical manifestations of SMF are a combination of attacks, areflexia, and ophthalmoplegia. To date, the autoimmune nature of the disease has been proven.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
V. V. Ponomarev
Clinical Hospital № 5
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Minsk
References
- Ferrer X., Ellie Е., Zarriviere et al. // J. Neurol. Neuros. Psych. — 1993. — Vol. 56. — P. 698—699.
- Fisher M. // Eng. J. Med. — 1956. — Vol. 255. — P. 57—67.
- Jibiki T., Shimizu N., Terashima J., Yuki N. // Rinsho-Sninkeidaka. — 1994. — Vol. 34. — P. 381—384.
- Kaiser-Smith Barone // J. Neurol. Neuros. Psych. — 1989. — Vol. 52. — P. 802—803.
- Ortuno A.D., Naerty C., Manor J. et al. // J. Neurol. Neuros. Psych. — 1990. — Vol. 53. — P. 615—616.
- Petty R.K., Duncan R., Jamal G.A. et al. HJ. Neorol. Neuros. Psych. — 1993. — Vol. 56. — P. 201—203.
- Ping-Rung Jip // J. Neurol. Neuros. Psych. — 1991. — Vol. 54. — P. 1121.
- Roberts M., Willison H., Vincent A. et al. // Lancet. — 1994. — Vol. 343. — P. 454—455.
- Willison H.J., Veitch J., Faterson G. et al. // J. Neorol Neuros. Psych. — 1993. — Vol. 56. — P. 204—206.
Supplementary files
